Ubisoft launches MONOPOLY: Star Wars Heroes vs. Villains, a team‑based twist on the classic board game featuring iconic Star Wars characters, cinematic battles, and strategic multiplayer modes.
Microsoft is weighing the cancellation of Marvel’s Blade and the closure of Arkane Studios, with at least five Xbox teams at risk as layoffs begin July 6.
Publisher 4Divinity and developer Eschatology Entertainment announce Guns of Eschaton, a Souls‑like FPS set in Viktor Antonov’s apocalyptic Western world, coming soon to PC and consoles.
SEGA unveils Rise Kujikawa’s Persona and support abilities in Persona 4 Revival, releasing February 18, 2027 on Xbox, PlayStation 5, Windows, and Steam.
State of Decay 3 developer Undead Labs has been named as another Xbox studio facing closure, with 110 jobs at risk amid Microsoft’s ongoing restructuring.
SNK announces Kenshiro is now available as the final Season 2 DLC fighter for Fatal Fury: City of the Wolves, with Season 3 starting July 2026. A mid‑year sale offers big discounts on the Legend Edition and Season Passes.
SEGA unveils Bakunawa Killer as a new playable character in Virtua Fighter Crossroads, revealed at Evo 2026. The game launches in 2027 with RGG Studio’s cinematic storytelling and deep combat mechanics.
SEGA announces Demon Slayer -Kimetsu no Yaiba- The Hinokami Chronicles 2 for Nintendo Switch™ 2, launching October 29, 2026 with the “Infinity Castle” Character Pass, upgraded visuals, and 54 playable characters.
One of the biggest talking points of Persona 4 Revival is the introduction of a brand‑new English voice cast, comprised of a lineup of industry veterans that fans will instantly recognize.
Warhorse Studios and Deep Silver celebrate Kingdom Come: Deliverance II surpassing 6 million copies sold worldwide, joining the Steam Summer Sale with discounts up to 80% and teasing future open‑world RPG projects.
Microsoft confirms a global Xbox console price hike effective August 1, 2026, citing rising component costs. The update includes $100–$150 increases, the end of the 2 TB model, and new financing and trade‑in programs.